BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37324258)

  • 1. Metabolic syndrome as risk factor for left ventricular hypertrophy in children with chronic kidney disease.
    Drożdż M; Moczulska A; Rudziński A; Drożdż D
    Front Endocrinol (Lausanne); 2023; 14():1215527. PubMed ID: 37324258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension.
    Paoletti E; De Nicola L; Gabbai FB; Chiodini P; Ravera M; Pieracci L; Marre S; Cassottana P; Lucà S; Vettoretti S; Borrelli S; Conte G; Minutolo R
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):271-9. PubMed ID: 26668021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD.
    Ruebner RL; Ng D; Mitsnefes M; Foster BJ; Meyers K; Warady B; Furth SL
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):1962-1968. PubMed ID: 27630183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FGF23 and Left Ventricular Hypertrophy in Children with CKD.
    Mitsnefes MM; Betoko A; Schneider MF; Salusky IB; Wolf MS; Jüppner H; Warady BA; Furth SL; Portale AA
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):45-52. PubMed ID: 29025789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nondipping pattern on 24-h ambulatory blood pressure monitoring is associated with left ventricular hypertrophy in chronic kidney disease.
    Jaques DA; Müller H; Martinez C; De Seigneux S; Martin PY; Ponte B; Saudan P
    Blood Press Monit; 2018 Oct; 23(5):244-252. PubMed ID: 29958233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [B-type natriuretic peptide as a marker of cardiac dysfunction in children with chronic kidney disease].
    Drożdż T; Kwinta P; Kordon Z; Sztefko K; Rudziński A; Zachwieja K; Miklaszewska M; Czarnecka D; Drożdż D
    Pol Merkur Lekarski; 2018 Apr; 44(262):171-176. PubMed ID: 29775443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the Method of Definition on the Prevalence of Left-Ventricular Hypertrophy in Children with Chronic Kidney Disease: Data from the Know-Ped CKD Study.
    Cho H; Choi HJ; Kang HG; Ha IS; Cheong HI; Han KH; Kim SH; Cho MH; Shin JI; Lee JH; Park YS
    Kidney Blood Press Res; 2017; 42(3):406-415. PubMed ID: 28689198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiposity, Sex, and Cardiovascular Disease Risk in Children With CKD: A Longitudinal Study of Youth Enrolled in the Chronic Kidney Disease in Children (CKiD) Study.
    Brady TM; Roem J; Cox C; Schneider MF; Wilson AC; Furth SL; Warady BA; Mitsnefes M
    Am J Kidney Dis; 2020 Aug; 76(2):166-173. PubMed ID: 32389356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation.
    Ulasi II; Arodiwe EB; Ijoma CK
    Ethn Dis; 2006; 16(4):859-64. PubMed ID: 17061738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Nighttime Masked Uncontrolled Hypertension With Left Ventricular Hypertrophy and Kidney Function Among Patients with Chronic Kidney Disease Not Receiving Dialysis.
    Fu X; Ren H; Xie J; Wang W; Li Y; Gao P; Chen N
    JAMA Netw Open; 2022 May; 5(5):e2214460. PubMed ID: 35616936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement and treatment of elevated blood pressure in the pediatric patient with chronic kidney disease.
    Swinford RD; Portman RJ
    Adv Chronic Kidney Dis; 2004 Apr; 11(2):143-61. PubMed ID: 15216486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Ambulatory Blood Pressure Load in Pediatric CKD.
    Lee J; McCulloch CE; Flynn JT; Samuels J; Warady BA; Furth SL; Seth D; Grimes BA; Mitsnefes MM; Ku E
    Clin J Am Soc Nephrol; 2020 Apr; 15(4):493-500. PubMed ID: 32160993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory blood pressure is better associated with target organ damage than clinic blood pressure in patients with primary glomerular disease.
    Wen RW; Chen XQ; Zhu Y; Ke JT; Du Y; Wang C; Lou TQ
    BMC Nephrol; 2020 Dec; 21(1):541. PubMed ID: 33308181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1-3.
    Wang CJ; Bao XR; Du GW; Wang Y; Chen K; Shen ML; Wang LZ
    Int Urol Nephrol; 2014 Aug; 46(8):1609-17. PubMed ID: 24839054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left-ventricular diastolic dysfunction in Korean children with chronic kidney disease: data from the KNOW-Ped CKD study.
    Kim JY; Lee Y; Kang HG; Ha IS; Cheong HI; Choi HJ; Han KH; Kim SH; Cho MH; Shin JI; Lee JH; Park YS; Cho H
    BMC Nephrol; 2020 Dec; 21(1):533. PubMed ID: 33297989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nocturnal pulse rate correlated with ambulatory blood pressure and target organ damage in patients with chronic kidney disease.
    Zhang J; Wen R; Yin J; Zhu Y; Lin L; Ye Z; Peng H; Wang C; Lou T
    J Clin Hypertens (Greenwich); 2019 Jan; 21(1):77-87. PubMed ID: 30597750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of etiology and complications in children with stage 5 chronic kidney disease].
    Zhong C; Chen YL; Yu XX; Yang Q; Shi YQ; Tan LW; Wang AS; Wu DQ; Zhang GF; Yang HP; Li Q; Wang M
    Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1109-1117. PubMed ID: 38018048
    [No Abstract]   [Full Text] [Related]  

  • 20. Different BMI cardiovascular risk thresholds as markers of organ damage and metabolic syndrome in primary hypertension.
    Litwin M; Sladowska J; Syczewska M; Niemirska A; Daszkowska J; Antoniewicz J; Wierzbicka A; Wawer ZT
    Pediatr Nephrol; 2008 May; 23(5):787-96. PubMed ID: 18253758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.